Endpoint definition ↥ FinnGen phenotype data 321302 individuals Apply sex-specific rule None 321302 Check conditions None 321302 Filter registries Hospital Discharge: ICD-10 L80-L99 Cause of death: ICD-10 L80-L99 16790 Check pre-conditions, main-only, mode, ICD version Look only at ICD versions H.D: 10 ; C.O.D: 10 16790 Check minimum number of events None 16790 Include endpoints L12_VITILIGO L12_OTHPIGMENTATION L12_SEBORRKERAT L12_ACANTHNIGRICANS L12_CORNSANDCALLOS L12_EPIDERMALTHICKOTH L12_ACQICTHY L12_ACQKERAT L12_KERATPUNCTATA L12_XEROSCUT L12_EPIDERMTHICKNAS L12_KERATODERMAINOTH L12_TRANSEPIDERMELIMINATION L12_PYODERMAGANGRENOSUM L12_DECUBITANSULCERANDPRESSURE L12_ATROPHICSKIN L12_LICHENSCLERATROPH L12_ANETODERMA L12_ATROPODERMAPASINI L12_ACRODERMATITIS L12_SCARCONDITIONS L12_STRIAEATROPHICAE L12_ATROPHICSKINNAS L12_HYPERTROPHICSKIN L12_GRANULOMATOUSSKIN L12_LUPUS L12_LOCALDCONNECTISSUEOTH L12_VASCULITISSKIN L12_ULCERLOWLIMB L12_OTHERDISSKINANDSUBCUTIS L12_SKININOTH 17834 L12_OTHERSKINSUBCUTIS Extra metadata Level in the ICD hierarchy 2 First used in FinnGen datafreeze DF2
FinnGen phenotype data 321302 individuals Apply sex-specific rule None 321302 Check conditions None 321302 Filter registries Hospital Discharge: ICD-10 L80-L99 Cause of death: ICD-10 L80-L99 16790 Check pre-conditions, main-only, mode, ICD version Look only at ICD versions H.D: 10 ; C.O.D: 10 16790 Check minimum number of events None 16790 Include endpoints L12_VITILIGO L12_OTHPIGMENTATION L12_SEBORRKERAT L12_ACANTHNIGRICANS L12_CORNSANDCALLOS L12_EPIDERMALTHICKOTH L12_ACQICTHY L12_ACQKERAT L12_KERATPUNCTATA L12_XEROSCUT L12_EPIDERMTHICKNAS L12_KERATODERMAINOTH L12_TRANSEPIDERMELIMINATION L12_PYODERMAGANGRENOSUM L12_DECUBITANSULCERANDPRESSURE L12_ATROPHICSKIN L12_LICHENSCLERATROPH L12_ANETODERMA L12_ATROPODERMAPASINI L12_ACRODERMATITIS L12_SCARCONDITIONS L12_STRIAEATROPHICAE L12_ATROPHICSKINNAS L12_HYPERTROPHICSKIN L12_GRANULOMATOUSSKIN L12_LUPUS L12_LOCALDCONNECTISSUEOTH L12_VASCULITISSKIN L12_ULCERLOWLIMB L12_OTHERDISSKINANDSUBCUTIS L12_SKININOTH 17834 L12_OTHERSKINSUBCUTIS Extra metadata Level in the ICD hierarchy 2 First used in FinnGen datafreeze DF2
Similar endpoints ↥ List of similar endpoints to Other disorders of skin and subcutaneous tissue based on the number of shared cases. Broader endpoints: Diseases of the skin and subcutaneous tissue Diseases of the skin and subcutaneous tissue Any event in hilmo or specialist outpatient Any ICDMAIN event in hilmo or causes of death Narrower endpoints: Seborrhoeic keratosis Other disorders of skin and subcutaneous tissue, not elsewhere classified Atrophic disorders of skin Ulcer of lower limb, not elsewhere classified Corns and callosities Show all endpoint correlations
List of similar endpoints to Other disorders of skin and subcutaneous tissue based on the number of shared cases. Broader endpoints: Diseases of the skin and subcutaneous tissue Diseases of the skin and subcutaneous tissue Any event in hilmo or specialist outpatient Any ICDMAIN event in hilmo or causes of death Narrower endpoints: Seborrhoeic keratosis Other disorders of skin and subcutaneous tissue, not elsewhere classified Atrophic disorders of skin Ulcer of lower limb, not elsewhere classified Corns and callosities Show all endpoint correlations
Summary Statistics ↥ Key figures All Female Male ? X Number of individuals Using example data: ID phenocode age FG1 EXAMPLE_ENDPOINT 45 FG1 ENDPOINT_XYZ 46 FG1 DEATH 47 FG2 EXAMPLE_ENDPOINT 30 FG2 EXAMPLE_ENDPOINT 30.1 FG3 ENDPOINT_XYZ 50 In this example the number of individuals is 2, since only 2 unique individuals (FG1 and FG2) have EXAMPLE_ENDPOINT events. Number of individuals 17265 10319 6946 ? X Unadjusted prevalence Using example data: ID phenocode age FG1 EXAMPLE_ENDPOINT 45 FG1 ENDPOINT_XYZ 46 FG1 DEATH 47 FG2 EXAMPLE_ENDPOINT 30 FG2 EXAMPLE_ENDPOINT 30.1 FG3 ENDPOINT_XYZ 50 In this example the unadjusted prevalence is 66 %. The unadjusted prevalence is the number of individuals having an endpoint divided by the total number of individuals. Here: 2 unique individuals (FG1 and FG2) have EXAMPLE_ENDPOINT events 1 individual (FG3) has no EXAMPLE_ENDPOINT event So the unadjusted prevalence is 2 / 3 = 66 %. Unadjusted prevalence (%) 5.60 5.95 5.14 ? X Mean age at first event Using example data: ID phenocode age FG1 EXAMPLE_ENDPOINT 45 FG1 ENDPOINT_XYZ 46 FG1 DEATH 47 FG2 EXAMPLE_ENDPOINT 30 FG2 EXAMPLE_ENDPOINT 30.1 FG3 ENDPOINT_XYZ 50 In this example the mean age at first event is 37.5. The mean age at first event for EXAMPLE_ENDPOINT is computed by: selecting individuals having EXAMPLE_ENDPOINT: FG1 and FG2 for these individuals, taking the age of their first event of EXAMPLE_ENDPOINT: 45 for FG1 and 30 for FG2 computing the mean of these values So the mean age at first event is Mean(45, 30) = 37.5. Mean age at first event (years) 56.41 54.55 59.19 ? X Follow-up Amount of time to look for the endpoint since entering the study. This is either either 1, 5, 15 years or the full study time from 1998 to 2019. Absolute risk Estimates the probability of dying from the current endpoint. Check the Documentation page for Mortality: absolute risk to get more details. Hazard Ratio (HR) and 95% Confidence Interval (CI) Measures how much the risk of dying increases (HR > 1) or decreases (HR < 1). Number of individuals (N) Number of individuals having the current endpoint and died during the follow-up time. Mortality Follow-up Absolute risk HR [95% CI] p N 1998–2019 0.04 2.98 [2.43, 3.66] 6.8e-26 2042 15 years 0.01 1.45 [1.22, 1.72] 2.2e-5 729 5 years 0.00 3.68 [3.20, 4.24] 3.2e-74 692 1 year 0.00 11.35 [9.67, 13.31] <1e-100 456 Age distribution of first events Year distribution of first events Cumulative Incidence
Key figures All Female Male ? X Number of individuals Using example data: ID phenocode age FG1 EXAMPLE_ENDPOINT 45 FG1 ENDPOINT_XYZ 46 FG1 DEATH 47 FG2 EXAMPLE_ENDPOINT 30 FG2 EXAMPLE_ENDPOINT 30.1 FG3 ENDPOINT_XYZ 50 In this example the number of individuals is 2, since only 2 unique individuals (FG1 and FG2) have EXAMPLE_ENDPOINT events. Number of individuals 17265 10319 6946 ? X Unadjusted prevalence Using example data: ID phenocode age FG1 EXAMPLE_ENDPOINT 45 FG1 ENDPOINT_XYZ 46 FG1 DEATH 47 FG2 EXAMPLE_ENDPOINT 30 FG2 EXAMPLE_ENDPOINT 30.1 FG3 ENDPOINT_XYZ 50 In this example the unadjusted prevalence is 66 %. The unadjusted prevalence is the number of individuals having an endpoint divided by the total number of individuals. Here: 2 unique individuals (FG1 and FG2) have EXAMPLE_ENDPOINT events 1 individual (FG3) has no EXAMPLE_ENDPOINT event So the unadjusted prevalence is 2 / 3 = 66 %. Unadjusted prevalence (%) 5.60 5.95 5.14 ? X Mean age at first event Using example data: ID phenocode age FG1 EXAMPLE_ENDPOINT 45 FG1 ENDPOINT_XYZ 46 FG1 DEATH 47 FG2 EXAMPLE_ENDPOINT 30 FG2 EXAMPLE_ENDPOINT 30.1 FG3 ENDPOINT_XYZ 50 In this example the mean age at first event is 37.5. The mean age at first event for EXAMPLE_ENDPOINT is computed by: selecting individuals having EXAMPLE_ENDPOINT: FG1 and FG2 for these individuals, taking the age of their first event of EXAMPLE_ENDPOINT: 45 for FG1 and 30 for FG2 computing the mean of these values So the mean age at first event is Mean(45, 30) = 37.5. Mean age at first event (years) 56.41 54.55 59.19
? X Follow-up Amount of time to look for the endpoint since entering the study. This is either either 1, 5, 15 years or the full study time from 1998 to 2019. Absolute risk Estimates the probability of dying from the current endpoint. Check the Documentation page for Mortality: absolute risk to get more details. Hazard Ratio (HR) and 95% Confidence Interval (CI) Measures how much the risk of dying increases (HR > 1) or decreases (HR < 1). Number of individuals (N) Number of individuals having the current endpoint and died during the follow-up time. Mortality Follow-up Absolute risk HR [95% CI] p N 1998–2019 0.04 2.98 [2.43, 3.66] 6.8e-26 2042 15 years 0.01 1.45 [1.22, 1.72] 2.2e-5 729 5 years 0.00 3.68 [3.20, 4.24] 3.2e-74 692 1 year 0.00 11.35 [9.67, 13.31] <1e-100 456
Follow-up Amount of time to look for the endpoint since entering the study. This is either either 1, 5, 15 years or the full study time from 1998 to 2019.
Absolute risk Estimates the probability of dying from the current endpoint. Check the Documentation page for Mortality: absolute risk to get more details.
Hazard Ratio (HR) and 95% Confidence Interval (CI) Measures how much the risk of dying increases (HR > 1) or decreases (HR < 1).
Number of individuals (N) Number of individuals having the current endpoint and died during the follow-up time.
Correlations ↥ Index endpoint: L12_OTHERSKINSUBCUTIS – Other disorders of skin and subcutaneous tissue GWS hits: 0
Survival analyses between endpoints ↥ Plot before Other disorders of skin and subcutaneous tissue after Other disorders of skin and subcutaneous tissue Loading survival analyses plot Table Loading survival analyses table Download CSV
Plot before Other disorders of skin and subcutaneous tissue after Other disorders of skin and subcutaneous tissue Loading survival analyses plot
Drugs most likely to be purchased after Other disorders of skin and subcutaneous tissue ↥ Download CSV